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ABSTRACT: The magainins, peptide antibiotics secreted by the frog Xenopus laevis, have previously been
shown to permeabilize phospholipid vesicles. To elucidate the mechanism of permeabilization, we have
conducted detailed kinetic studies of magainin 2 amide (mgn2a)hduced release of 6-carboxyfluorescein
from vesicles of phosphatidylserine. The results show that dye release occurs in (at least) two stages-an
initial rapid phase, with t l p = 3 s, followed by a much slower phase that approaches zero leakage rate before
all the dye is released. Light-scattering studies showed that mgn2a does not cause gross changes in vesicle
structure. The peptide was found to rapidly equilibrate betweenvesicles;this was demonstrated by determining
a binding isotherm for the peptidelipid interaction, and by showing that addition of unloaded vesicles
rapidly quenches peptide-induced leakage from loaded vesicles. Transient dye release in the presence of
an equilibrating peptide can be explained in two ways: (1) the peptide exists only transiently in an active
form; (2) the vesicles are only transiently leaky. Preincubation of mgn2a at assay concentrations in buffer
alone or with unloaded vesicles did not inactivate the peptide. Therefore, rapid leakage is probably due
to transient destabilization of the vesicle upon addition of mgn2a.

The magainins, a class of antimicrobial peptides secreted
fromtheskinof thefrogxenopus laevis (Zasloff, 1987; Zasloff
et al., 1988), are thought to kill cells by permeabilizing the
plasma membrane. A total of 23 residues in length and bearing
a positive chargeof +3 to +5 at physiologicalpH, these peptides
could potentially form amphipathic helical structures that
are able to disrupt lipid bilayers or form oligomeric transmembrane channels [seeWilliams et al. (1990) and references
cited therein].
Evidence that magainins can act directly on lipid bilayers
comes from studies with planar bilayers and liposomes.
Duclohier et al. (1989) found that magainin 1 forms anionselective channels in planar lipid bilayers under conditions of
high salt and high trans-negative potential. Several conductance states were identified, the lowest being 80 pS. The dose
response curves suggested that the magainin channel consists
of three to six monomers.
When magainin 2 amide (mgn2a)l or its analogs were added
to respiring cytochrome oxidase-containing liposomes (which
have an inside-negative membrane potential), Juretic et al.
(1989) found that the peptides uncouple respiration and cause
a stable (rather than transient) decrease in the steady-state
membrane potential. The sigmoidaldose response curve was
attributed to magainin monomers interacting cooperatively
in the membrane to form an active aggregate of four to five
subunits.
These two studies suggest that the mechanism of magainin
action is similar to that proposed for other voltage-dependent
pore-formers, such as alamecithin [reviewed by Stein (1 986)].
According to the model, monomers or aggregatesof the peptide
initially bind to the bilayer interface (through a combination
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of electrostatic and hydrophobic interactions) as an inactive
amphipathic a-helix. The inactive form is then driven into
the bilayer by the membrane potential, whereupon the peptide
forms an active transmembrane pore. Changesin aggregation
state can occur before, during, or after voltage-induced
transmembranal insertion.
There is, however, evidenceto show that magainin effectively
permeabilizes liposomes in the absence of a membrane
potential: When magainin 1 was added to sonicated phosphatidylserine (PS)vesicles, Matsuzaki et al. (1989a) found
that entrapped calcein was rapidly released, on a time scale
of seconds to minutes. By measurement of the initial rate of
leakage as a function of total peptide and total lipid
concentration, an equilibrium binding isotherm for the peptidelipid interaction was also determined. The resulting curve,
which fit well to the Langmuir equation, suggested to
Matsuzaki et al. that extensive aggregation of peptide on the
vesicle does not occur. From this, they concluded that
magainin 1probably does not form oligomeric channelsin the
bilayer, and therefore functions instead as a bilayer destabilizer. An important caveat, which they noted, is that their
binding data are not sensitive enough to rule out the possibility
that a small fraction of the peptide forms oligomeric channels.
In our opinion, binding isotherms are exceedingly difficult to
interpret because steric effects and changes in membrane
surface potential lead to large activity coefficient effects that
are hard to predict quantitatively (Schwarz et al., 1986).
To help clarify the mechanism of magainin’s lytic action,
we have studied in detail the kinetics of mgn2a-induced release
of 6-carboxyfluorescein (CF) from phosphatidylserineliposomes in the absence of a membrane potential. Our results
show that the fast release of dye is a transient effect. After
experimentallyeliminatingseveral explanations, we conclude
that fast release results from transient destabilization of the
bilayer upon initial interaction with the peptide. A unifying
mechanism for magainin action is proposed.

EXPERIMENTAL PROCEDURES
Materials. Phosphatidylserine (bovine brain) was purchased from Avanti Polar Lipids; Triton X-100, especially
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purified for membrane research, was from Boehringer Mannheim. Carboxyfluorescein from Eastman (>99%) was used
for most of these studies, without further purification;
chromatographically pure CF (Molecular Probes) was also
used in selected experiments, and gave results indistinguishable
from those obtained with Eastman CF. Magainin 2 amide
was a generous gift from Dr. Hao-Chia Chen.
Buffers. Buffers used in SUV studies were as follows: buffer
A, 10 mM Pipes, 150 mM NaCl, 1 mM EDTA, and 100 mM
sucrose, pH 7.0; buffer B, 10 mM Pipes, 150 mM NaC1,’and
1 mM EDTA, pH 7.0; dye solution, 100 mM CF, 10 mM
Pipes, 150 mM NaCl, and 1 mM EDTA, pH 7.0.
Preparation of Small Unilamellar Vesicles ( S W s ) . Because the phase transition of the bovine brain PS is 8 “C,
SUVs and LUVs had to be prepared and stored above this
temperature; for convenience, all procedureswere carried out
at or near room temperature.
Approximately 20 mg of PS in 2 mL of solvent was dried
to a film in a 25-mL flask by rotary evaporation, redissolved
in 5 mL of benzene, and lyophilized overnight under high
vacuum. The lyophilized lipid was then suspended in 2 mL
of dye solution by vortex mixing, transferred to a polycarbonate
tube, and sonicated (under argon) at 25-30 OC to constant
clarity in a cup horn using a Heat Systemsultrasonic sonicator
(W-375). Unentrapped CF was removed from the solution
by passing the sonicate through an Econo-Pac lODG column
(10 mL) using buffer A as the eluting buffer.
To obtain a homogeneous population of SUVs, larger
particles were removed by sedimentation in an angle rotor
(Ti50, Beckman ultracentrifuge), as described by Barenholz
et al. (1977). Centrifugation at 45K rpm for 15 min was
sufficient to produce a population of CF-loaded lipsomes that
elutes as a homogeneous population of SUVs from a Sepharose
2B-CL column: A single, well-included peak was obtained,
with a constant ratio of CF/phosphate across the elution
profile. This result also shows that the vesicles are relatively
stable, since vesicle breakdown or fusion usually produces a
heterogeneous mixture of particles. Lipid phosphate was
determined by the method of Bartlett (1959).
Preparation of Large Unilamellar Vesicles ( L W s ) . CFloaded PS LUVs were prepared by the reverse-phase ether
evaporation method (Diizgiines et al., 1983), using 100 mM
CF, 10 mM Pipes, 10 mM NaC1, and 1 mM EDTA, pH 7.0
(296 mOsM), as the aqueous phase. The initially formed
vesicles were extruded successively through Nucleopore filters
of 0.4, 0.2, 0.1, and 0.08 pm. To remove unentrapped CF
and contaminating SUVs, the vesicles were passed through
an Econo-Pac lODG column (10 mL) and then a Sepharose2BCL column (1.6 X 60 cm), using 10 mM Pipes, 150 mM
NaC1, and 1 mM EDTA, pH 7.0 (295 mOsM), as the eluting
buffer.
CF Release Assay. Release of CF from the vesicles at 25
“C was determined fluorometrically by monitoring the
decrease in self-quenching (excitation 490 nm, emission 520
nm; Aminco SPF-5OOC spectrofluorometer) as the dye is
released from the vesicles (Weinstein et al., 1984).
Kinetic experiments were usually initiated by injecting 5-20
pL of peptide stock solution (0.37 mM mgn2a in buffer B)
into a magnetically stirred, equilibrated cuvette containing 2
mL of 25-30 pM PS in buffer A. The mixing time was about
1 s. At the end of each run, the total releasable fluorescence
wasdeterminedby theadditionof 20pLof lO%TritonX-lOO.
Progress of the reaction is reported as the percentage of CF
quenched, %Q,which is calculated from the formula [ 1 - (F,
- F0)/(Fm- Fo)]100, where F,is the fluorescence at time t,
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FOis the base-line fluorescence of the vesicles, and F, is the
fluorescence after Triton X-100 addition. As will be shown
under Results, mgn2a induces the release of dye by an allor-none mechanism. Consequently, %Q equalsthe percentage
of total dye remaining in the vesicles.
The kinetics of dye release from SUVs were not significantly
affected by the osmolarity of the bathing solution. This was
determined by varying the osmolarity of buffer B from 33 1
to 804 mOsM with sucrose. The osmolarity of the dye solution
was 600.
Isoosmotic conditions were used to measure the release of
dye from LUVs, using the dye solution and external buffer
described above in the section on LUV preparation.
Mode of Dye Release. Dye may be released from a
population of vesicles by an “all-or-none”or a ”graded”process;
the all-or-none mode of release produces a mixture of fully
loaded and completely unloaded vesicles whereas the graded
mode produces a population of vesicles that are all partially
unloaded to the same extent. These two modes of release can
be distinguished by determiningthe percentageof fluorescence
quenching remaining in the intravesicular medium, %Qtr,after
a substantial fraction of dye has been released from thevesicle
sample (Weinstein et al., 1984).
To determine the mode of release, mgn2a was added to
SUVs (25-30 pM PS) containing either 30 mM or 100 mM
entrapped CF. After 100 or 500 s, an aliquot of unloaded
vesicles (6 pL of 85 mM PS) was added to quench the mgn2ainduced release of dyevia intervesicular equlibration of peptide.
To separate the vesicles from released dye, 1-mL aliquots of
the mgn2a/SUV mixture were rapidly passed over 5-mL
SephadexG25 columns by centrifugation at a maximum speed
for 15s (at room temperature) in a clinical centrifuge. Vesicle
fractions of 0.5 mL were then analyzed in the absence and
presence of Triton X-100 to determine the percentage of
fluorescencequenching. From these results, the intravesicular
concentration of CF could be determined from a standard
quench curve, which was obtained by measuring the fluorescence quenching of vesicle samples prepared in solutions
ranging from 1 to 100 mM CF.
Light Scattering. To determine whether mgn2a induces
gross structural changesof the vesicles by fusion, aggregation,
or solubilization, changes in the 90” light scattering of vesicle
solutions were monitored with the spectrofluorometer. An
incident wavelength of 400 nm was used, with band-pass slit
settings at 4 nm.
Even if no gross structural changes take place, a modest
increase in light scattering is expected because bound peptide
increases the mass of the vesicle and perhaps the refractive
index increment as well. The predicted magnitude of these
increases was calculated as described previously by Roseman
et al. (1977) in a study of cytochrome bs-vesicle interactions.
Briefly, the Rayleigh equation shows that the relative increase
in light scattering of an SUV-peptide complex compared to
SUV alone depends on three ratios: the relative molecular
weights, the relative concentrations in grams per milliliter,
and the relative refractive index increments. From our
experimentally determinedmgn2a-lipid binding isotherm, the
relative molecular weights and relative concentrations of
particles could readily be calculated. The refractive index
increments, which were not measured, had to be estimated
fromreported values for pure lipid (0.1478 mL/g) and protein
(range: 0.15-0.2 mL/g); for thesecalculations,it was assumed
that the refractive index increment of a complex is a simple
weighted average of the refractive index increments of the
pure components.

Grant et a].

9914 Biochemistry, Vol. 31, No. 41, 1992
A
B

100

r\

104

1

0.00

v

.

I

I

100

Mo

I

I

1

I

3 0 0 4 0 0 s o a s o o

TIME (seconds)

FIGURE
1: mgn2a-indud release of CF from PS SUVs. 5-20 pL
of 0.37 mM mgn2a (in buffer B) was injected into a stirred cuvette
containing a 2-mL solution of CF-loaded SUVs (30 pM in PS) in
buffer A, and the increase in fluorescence intensity (excitation 490,
emission 520) was monitored. See Experimental Procedures for
further experimental details. The final concentrations of mgn2a in
the six reaction mixtures A-F were, respectively, 0,1.30, 1.852.22,
2.78, and 3.70pM.
100

0.15

I

I

/

0.00

I

I

I

I

0.20

0.40

0.60

0.80

I

1.@I

[Plf (PM)
FIGURE
3: Binding isotherm for the interaction of mgn2a with CFloaded PS SUVs.
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FIGURE
4: Dose response curve relating leakage rate to the ratio of
moles of peptide bound per mole of lipid.
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FIGURE
2: Leakage rate as a function of total peptide concentration
at four concentrations of SUVs. The concentrations of PS were 25
(diamonds),50 (squares), 75 (circles), and 100 rM (triangles).The
leakage rate is defined as the percentage of dye released in the first
minute.

RESULTS
Effect of mgn2a on the Permeability of PSSUVs. As shown
in Figure 1, addition of mgn2a to PS SUVs causes the release
of CF, but the kinetics are not simple first order; dye is released
in a rapid initial phase, lasting about 100 s, followed by a
much slower phase.
To narrow down the number of plausible explanations for
these kinetics, it is necessary to know (1) whether the peptide
readily equilibrates between vesicles, (2) the number of
peptides bound per vesicle, and (3) whether the peptide induces
gross structural changes in the vesicles.
Determination of a Binding Isotherm for the mgn2a-PS
Interaction. A binding isotherm for the mgn2a-PS SUV
interaction was obtained by the “indirect method”, which has
been used to determine the affinity of permeabilizing agents
for cells or liposomes (Thron, 1964; Matsuzaki et al., 1988,
1989b). The first step, as shown in Figure 2, is to measure
the fractional leakage rate (%Q/s) as a function of peptide
concentration at several fixed concentrations of lipid. Next,
a set of lines parallel to the x axis is drawn through the four
dose response curves, giving for each line four pairs of [PO],-

[L] values that produce an equivalent fractional leakage rate.
[PO]and [L], the total molar concentrations of peptide and
lipid, respectively,are functionally related to the concentrations
of bound and free peptide by the conservation equation:
[Pol = [Pfl + r [ L l
where [Pf] is the concentration of free peptide and r is the
molar solution concentration ratio of bound peptide per lipid.
Sinceall pairs of [PO],[L] values that produce a given fractional
leakage rate must also produce the same value of r, plots of
[PO]versus [L] at constant fractional leakage rates are linear,
withslopesofrandinterceptsof [Pf]. Thesetofr,[Pf]obtained
from these plots constitutes the binding isotherm, shown in
Figure 3. From the slope of a line drawn through the
experimental points, an apparent binding constant of 1.12 X
lo5 M-’was obtained.
A dose response curve relating the fractional leakage rate
to the amount of peptide actually bound is shown in Figure
4. The experimental points lie on a straight line that
extrapolates to an intercept of r = 0.03, which is the “critical
number” of peptide monomers that must be bound per mole
of lipid to induce leakage. In our kinetic experiments,rvaried
from 0.06 to 0.14, which corresponds to 60-250 peptide
molecules bound per SUV. Because this ratio is so high, no
vesicle was devoid of peptide during a kinetic run.
Although binding isotherms are frequently used in attempts
to deduce the state of peptide aggregation on the vesicle surface,
definitive interpretations are not always possible because it is
difficult to take into account steric effects and changes in

Biochemistry, Vol. 31, No. 41, 1992 9915

Permeabilization of Liposomes by Magainin 2 Amide

~

Table I: mgn2a-Induced Increases in Light Scattering of SUVs'

Table 11: Mode of mgn2a-Induced Dye Release from SUVs'

predicted changes in iJiv
[mgn2a]
(rMlb

with no fusion
or aggregationC

0.93
1.30
1.85
2.22
2.78
3.70

1.17-1.23
1.25-1.34
1.34-1.47
1.44-1.61
1.56-1.78
1.77-2.09

with fusion
or aggregationd
>2.34
>2.50
>2.68
>2.88
>3.12
>3.54

observed
1.31
1.23
1.54
1.91
1.92
2.38

The relative increase in 90° light scattering (ic/iv)was determined
with a spectrofluorometer as described under Experimental Procedures.
5-20 pL of 0.37 mM mgn2a was added to SUVs ([PSI= 30 pM) in
buffer A, vesicles contained 100 mM entrapped CF. An immediate
increase in light scatteringwas observed, which showed no further change
over 500 s. Range of values reflects uncertainty in the refractive index
increment (see Experimental Procedures). Lower limit estimate, assuming all peptidevesicle complexes double in mass. The values were
obtained by multiplying the smaller number in the previous column by
a factor of 2.

vesicle surface potential upon peptide binding (Schwarz et
al., 1986). We shall avoid any attempt to do so here.
For our purposes, the most important result is that the
mgn2a-vesicle interaction appears to be reversible. This was
substantiated by the following experiment. To a mixture of
3.7 pM mgn2a and loaded SUVs (30 pM PS) was added 5
p L of unloaded vesicles (11.5 mM PS) at 10, 30, and 60 s
after the peptide was injected. In each case, leakage stopped
almost instantly after injection of unloaded vesicles. The most
reasonable conclusion is that the level of mgn2a bound to the
loaded vesicles was reduced by peptide equilibrating between
loaded and unloaded vesicles.
Light-Scattering Studies. To determine whether mgn2a
causes gross structural changes in the SUVs,the 90° light
scattering of a vesicle solution was measured before and after
addition of peptide. As shown in Table I, peptide causes a
dose-dependent increase in the relative light scattering, up to
a value of 2.38. This increase can be attributed mainly to the
increase in mass and perhaps refractive index increment of
the particles contributed by the peptide, as shown by the
theoretical calculations in column 2.
Column 3 shows the theoretical lower limit for a lightscattering increase that would occur if all the initial SUVs
(with bound peptide) uniformly increased in size by undergoing
a single fusion event. Clearly, these values are substantially
higher than the ones observed. Moreover, this lower limit
prediction is highly conservative, if not unrealistic, since it
has never been observed (to our knowledge) that bilayerdestabilizing peptides or proteins cause such a controlled,
limited aggregation or fusion of vesicles; in all reported studies
of protein- or peptide-induced fusion [reviewed in Maezawa
et al. (1989)],the protein or peptide causes massive aggregation
of vesicles, or the formation of a heterogeneous dispersion of
vesicles that results from multiple fusions. It should also be
noted that the kinetics of aggregation or fusion are usually
sufficiently slow (with half-times of a few seconds to minutes)
that time-dependent changes in light scattering are observed
upon addition of peptide or protein. In our experiments,
however, the changes in light scattering appear to be
instantaneous and do not increase with time.
From our results, calculations, and the reported effect of
known fusogens on lipid vesicles, we conclude that mgn2a
does not induce a significantfusion or aggregation of PS SUVs.
KineticStudiesof the Biphasic Releaseof CF. Since mgn2a
(includingany lytic form) rapidly equilibratesbetween vesicles,
a simple model whereby the peptide reversibly forms channels

[mgn2a]
(pM)

duration of
run (s)

0
1.85
2.22
2.78
3.70
0
1.85
2.22
2.78
3.70

100

%CF
release

predicted %Q
all-or-none graded
release
release

observed

0
80
13
80
78
82
17
80
77
80
80
28
80
74
64
80
56
79
500
0
80
18
80
77
80
30
80
73
80
50
80
67
79
82
80
36
76
SUVs (25-30 pM in PS) started with 30 mM entrapped CF. Details
of how both the predicted and observed values were obtained are given
under Experimental Procedures. The error in %Q is &1.5%.

cannot explain why only a fraction of the dye is released in
the fast phase. One possibility is that magainin is inactivated
during the initial 100 s by interaction with the vesicles. This
was tested by preincubating mgn2a (1.85-3.7 pM) with
unloaded vesicles (5 r M in PS) for 100 s before addition of
loaded vesicles (final [PSI = 25 pM). Fast release was still
observed (data not shown), of a magnitude predicted for this
ratio of loaded to unloaded vesicles. Evidently, the peptide
remains active.
Biphasic kinetics could also arise from putative highly lytic
peptide aggregates that exist in the concentrated stock solution,
but which disaggregate in the assay mixture. This was tested
by preincubating mgn2a for up to 24 h in the cuvette at assay
concentrations before adding vesicles. The release kinetics
were essentially the same, making this explanation unlikely.
[It should be noted that in these experiments the cuvette
was rinsed with mgn2a solution before adding the preincubation solution. Without the prerinse, the activity of mgn2a
decreases slowly if the solution is allowed to stand and decreases
rapidly if the solution is continuously stirred. The simplest
explanation is that in the absence of lipid, the cationic peptide
adsorbs to the glass walls of the cuvette, and that stirring
accelerates this process by eliminating diffusion as a ratelimiting step. Tosteson et al. (1985) have previously reported
that melittin, a positively charged peptide, also binds to glass.]
If the intrinsic activity of the peptide remains constant,
then it must be the vesicles that undergo transient changes.
Some insight into the nature of these events can be obtained
from determining the mode of dye release.
As discussed earlier, dye may be released in an all-or-none
or a graded fashion. These mechanisms are distinguished by
measuring the percent quenching remaining in the vesicles,
after a significant fraction of total dye has been released;
if release is all-or-none,%Qtrstays constant, whereas if release
is graded, %Qtrdecreases by an amount that can be determined
from a standard quench curve.
After addition of mgn2a to the vesicles, the residual
quenching of entrapped dye was determined near the end of
the fast phase (100 s) and at a later time point (500 s) in an
attempt to discern the mode of release for each phase of the
reaction. The results are shown in Table 11. By comparing
theexperimental results with those predicted for the twomodes
of release, it is clear that release is all-or-none during the first
100 s.
A similar comparison of %Qtrat 500 s appears to indicate
that all-or-none release continues through the slow phase as
well. However, before drawing such a conclusion, it must be
shown that in theory, a purely all-or-none release would

%etr,
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FIGURE5: Effect of adding successive additions of mgn2a to loaded
SUVs. mgn2a was added to SUVs of 29 pM PS. Curve A: 1.11nmol additions were made at f = 0, 109, and 234 s. Curve B: 1.85nmol additions were made at t = 0,109, and 204 s. Curve C: 2.59nmol additions were made at t = 0,99, and 194 s. Curve D: 3.70nmol additions were made at t = 0 and 115 s. Arrows indicate the
times of addition.

produce a significantly different %Qt,than a process involving
a change fromall-or-noneto graded. Using a standard quench
curve, a calculation showed that it is possible to discern the
mode of release during the slow phase, but only in the runs
where the two highest levels of mgn2a were used, i.e., 15 and
20 pg. In those cases, a sequential bimodal release (all-ornone followed by graded) should have produced final %Qtr
values of 74 and 64%, respectively; these differ sufficiently
from the starting %Qtr,so that a bimodal release could have
been detected if it had occurred. From the experimentally
determined values of 79 and 76%, we conclude that release
over the 100-500-s interval is primarily all-or-none.
There are two ways that lysis of the vesicles could arise.
Interaction with peptide could induce instability into the
vesicles, which then relax to stable proteoliposomes accompanied by lysis of a fraction of the vesicles. (Stability is defined
here as the lowest free energy for vesicles of a given size.)
Alternatively, the vesicles might start out in a metastable
form before the peptide is added. If so, the peptide would
function solely as a catalyst that facilitates relaxation of the
unstable vesicles to a more stable structure, accompanied by
lysis of a fraction of the vesicles. Preexisting metastability
could result from the method of preparation, such as sonication.
These alternatives can be distinguished by adding more
magainin at the end of the fast phase. If the peptide induces
instability, another fast phase should be observed, but if it
acts catalytically, the vesicles should all be relaxed by the
time of the second peptide addition; consequently, no additional
fast-release phases should occur.
As shown in Figure 5 , a new fast phase is induced with each
addition of peptide, indicating that lysis arises from peptideinduced vesicle instability rather than preexisting vesicle
instability.
In further support of this conclusion, we find that mgn2a
induces biphasic release of dye from LUVs (data not shown),
the only difference being that approximately half as much
mgn2a is required to achieve the same %Q as with SUVs.
Since LUVs are not produced by sonication, and are too large
to be affected by curvature-induced strain, whatever might
cause the putative metastability of SUVs is unlikely to be
present in LUVs.
Kinetics of Detergent-Induced Dye Release. As shown
earlier, mgn2a does not begin to induce measurable CF release

until the level of bound peptide becomes quite high, at r =
0.03. To compare the intrinsic permeabilizing activity of
mgn2a with that of detergents, the effect of octyl glucoside
and Triton X-100 on CF release from PS SUVs was
determined. From the leakage kinetics and the published
values of the bilayer/water partition coefficients for these
detergents (Paternostre et al., 1988), dose response curves
relating r to the fractional leakage rate can be obtained. Our
results (not shown) are essentially the same as those reported
by Lasch et al. (1990) in a study of the effect of these detergents
on the release of CF from LUVs of egg PC: measurable
leakage was not observed until the r values for Triton X-100
and octyl glucoside reached about 0.07 and 0.175, respectively.
[The leakage rate sharply increases at r = 0.42 (Triton X- 100)
and r = 0.23 (octyl glucoside); these are the upward turning
points of the sigmoidal dose response curves.]
When compared on a weight basis (grams per mole of lipid),
the r values at leakage onset for mgn2a, Triton X-100, and
octyl glucoside are remarkably similar-81, 44, and 51,
respectively.

DISCUSSION
The simplest model that is at least qualitatively consistent
with all of our results is the bilayer destabilization mechanism,
shown in Scheme I.
In the first step, peptide reversibly binds to the vesicles to
form a destabilized vesicle, PV*.Destabilization is suggested
to arise from a packing imbalancecreated by the accumulation
of peptide on or in the outer monolayer of the vesicle. PV*
then undergoes a rapid, irreversible relaxation, perhaps by
lipid translocation, to a more stable proteoliposome, PV’, which
exists in equilibriumwith free peptide. Although the scheme
suggests that the stable vesicle V‘ is devoid of protein, V‘
represents a proteoliposomewith an equilibrium level of peptide
bound to the outer monolayer; the packing and distribution
of lipid in this proteoliposome is a variable that is dictated by
the amount of protein bound to the surface. At the end of the
fast release phase, the only species present are PV’, P, and V’.
During the lifetime of PV*, fluctuating pores (V,) form
within the lipid bilayer. In the scheme, the conversion of PV*
to PV, represents the rate of forming pores large enough to
release CF. It is assumed that once a pore this large is formed,
all the dye is released from that vesicle before the pore
dissipates. Therefore, the rate-limiting step in the release of
dye from PV* is the conversion of PV* to PV,; the arrow
leading back from PV, to PV* represents the dissipation of
a pore in an unloaded vesicle.
This model accounts for the limited fast release of dye by
an all-or-none mechanism in a system with a persistently active
peptide that exchanges between vesicles. To account for the
observation that further addition of peptide at the end of the
fast phase induces another fast phase (Figure 5), we suggest
that V’ must undergo further destabilization and relaxation
to accommodate a higher level of peptide.
For this minimal model, only one transiently destabilized
form of the vesicle (PV*) is postulated. If relaxation occurs
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through a series of intermediates, the reaction scheme can be
expanded according to the general form shown in Scheme I1
where the rate constants with even-numbered subscripts
represent the leak rate from each intermediate and k, is the
final leak rate in the slow phase. If the free and bound peptides
are in rapid equilibrium, the rate equation for this mechanism
simplifies to a sum of first-order exponentials:
F = A exp[-(k,

+ k2)t]+
B exp[-(k,

+ k4)t]...+ Z exp(-k2t)

where Fis the percentage of the vesicle population that contains
dye and is equal to %Q because the mode of release is allor-none. The preexponential terms are complex expressions
of rate constants.
A nonlinear least-squares analysis (Bevington, 1969)of our
%Q vs t curves indicates that at the highest levels of added
mgn2a (where the signal/noise ratio is most favorable) the
kinetics are closely fit by a triexponential, %Q = A exp(-kat)
B exp(-kbt) C exp(-k,t)
D, with the following values
for the constants, in s-l: A = 41.6, k, = 0.192; B = 26.9, kb
= 0.00756; C = 23.2, kc = 0.0011; D = 5.71. These results
suggest that vesicle relaxation is a multistep process.
The alternative to bilayer destabilization is that the peptide
forms transient oligomeric channels in the bilayer, but the
only reasonable explanation for the transient nature of such
a putative channel is that it exists only in a transiently
destabilized bilayer. If so, the function of the channel is
superfluous since a destabilized bilayer itself is a breach of
the permeabilitybarrier. Therefore, explanationsbased upon
peptide-lined pores are hard to rationalize.
Sincewe favor a bilayer destabilization mechanism, it would
be informative to compare the characteristics of mgn2ainduced leakage with the characteristics of detergent-induced
leakage. In particular, we would like to know whether
detergents ever induce biphasic release kinetics, cause leakage
by an all-or-none mode of release, or have a specific activity
comparable to that of mgn2a.
Somedetergents do show biphasic release kinetics: Schubert
et al. (1986) and Lasch et al. (1990) have found that cholate
and deoxycholaterelease only a fraction of entrapped solute
(the extent of which depends on the amount of detergentadded)
even after prolonged times. Schubertet al. suggest that leakage
is due to the formation of transient holes in the bilayer, which
is essentially what we are proposing to account for mgn2a
action.
To our knowledge, all-or-none release has not been looked
for in studies with liposomes. However, it has been shown
that detergents can induce an all-or-none lysis of cells (Scharff,
1960; Maas, 1969; Silhankova, 1959) and some detergents
cause discrete conductance fluctuations in planar bilayers
(Blumenthal & Klausner, 1982).
The specific activities of mgn2a and detergents are comparable. Leakage onset does not occur until the levels of bound

+

+

+

magainin (on a weight basis of grams per moleof phospholipid)
equal or exceed the high critical values observed with
detergents: for mgn2a, 8 1; Triton X- 100,44; octyl glucoside,
5 1. Although it seems fortuitous that a cationic amphipathic
peptide should have a comparable activity to two neutral
detergents, it is interesting to note that cholate, with an
amphipathic architecture and charge that is different from
Triton X-100 and octyl glucoside, also shows a similar critical
r value: the release of raffinose from egg PC LUVs does not
occur until r equals about 0.15 (Schubert et al., 1986), which
is 65 g of cholate/mol of phospholipid.
As noted earlier, magainin forms channels in highly
polarized (>lo0 mV) planar lipid bilayers composed mainly
or exclusivelyof neutral phospholipids (Duclohier et al., 1989).
In contrast, we have observed (unpublishedobservation) that
addition of mgn2a to planar bilayers composed of PC/PE/PS
under a trans-negative potential of <80 mV increases the
macroscopic conductance without evidence of discrete conductance states. Also, although liposomes of the same lipid
composition are readily permeabilized by mgn2a, when mgn2a
was added to the planar bilayers in the presence of liposomes
(to maintain the same protein:lipid ratio that induces rapid
dye release from the liposomes), no significant change in
membrane conductance was seen.
From our results and those obtained by others, we can
explain the action of magainin in a variety of model membrane
systems by making three assumptions. First, an increase in
the negative charge of the membrane increases the affinity of
the bilayer for the cationic peptide, which promotes transient
bilayer destabilization and leakage. Second, an increase in
the negative surface charge of the membrane from anionic
phospholipids inhibits voltage-induced channel formation by
causing the peptide to remain bound in an electrically neutral
(and therefore potential-insensitive) complex at the vesicle
surface or interface. Third, planar bilayers are more resistant
than liposomes to peptide-induced transient destabilization
because planar bilayers can relieve the strain by transferring
lipid into or out of the torous or by bending in either the cis
or the trans direction.
To summarize, mgn2a can permeabilize membranes via
bilayer destabilization or by channels. Which mechanism
predominatesdepends on the membrane system, composition,
and degree of polarization.

REFERENCES
Barenholz, Y., Gibbes, D., Litman, B. J., Goll, J., Thompson, T.
E., & Carlson, F. D. (1977) Biochemistry 16, 2806-2810.
Bartlett, G. R. (1959) J. Biol. Chem. 234, 466-468.
Bevington, P. R. (1969) Data Reduction and Error Analysisfor
the Physical Sciences, pp 212-21 3, McGraw-Hill, New York.
Blumenthal, R., & Klausner, R. D. (1982) in Membrane
Reconstitution (Poste, G. & Nicolson, G. L., Eds.) pp 43-82,
Elsevier Biomedical Press, New York.
Duclohier, H., Molle, G., & Spach, G. (1989) Biophys. J . 56,
1017-1021.
Diizgiines, N., Wilschut, J., Hong, K., Fraley, R., Perry, C.,
Friend, D., James, T. L., & Papahadjopoulos, D. (1983)
Biochim. Biophys. Acta 732, 289-299.
Juretic, D., Chen, H.-C., Brown, J. H., Morell, J. L., Hendler,
R. W., & Westerhoff, H. V. (1989) FEBSLett. 249,219-223.
Lasch, J., Hoffmann, J., Omelyanenko, W. G., Klibanov, A. A.,
Torchilin, V. P., Binder, H., & Gawrisch, K. (1990) Biochim.
Biophys. Acta 1022, 171-180.
Maas, M. (1969) Thesis, Leiden, The Netherlands.
Maezawa, S.,Yoshimura, T., Hong, K., Diizgiines, N., &
Papahadjopoulos, D. (1989) Biochemistry 28, 1422-1428.

9918

Biochemistry, Vol. 31, No. 41, 1992

Matsuzaki, K., Handa, T., Miyajima, K., Mikura, Y., Shimiza,
H., & Toguchi, H. (1988) Chem. Pharm. Bull. 36, 42534260.

Matsuzaki, K., Harada, M., Handa, T., Funakoshi, S.,Fujii, N.,
Yajima, H., & Miyajima, K. (1989a) Biochim. Biophys.Acta
981, 130-134.

Matsuzaki, K., Nakai, S.,Handa, T., Takaishi, Y., Fujita, T.,
& Miyajima, K. (1989b) Biochemistry 28, 9392-9398.
Paternostre, M.-T., ROUX,M., & Rigaud, J.-L. (1988) Biochemistry 27, 2668-2617.
Roseman, M. A., Holloway, P. W., Calabro, M. A., & Thompson,
T. E. (1977) J. Biol. Chem. 252, 4842-4849.
Scharff, T. G. (1960) Biochem. Pharmacol. 5, 79-86.
Schubert, R., Beyer, K., Wolburg, H., & Schmidt, K.-H. (1986)
Biochemistry 25, 5263-5269.
Schwarz, G., Stankowski, S., & Rizzo, V. (1986) Biochim.
Biophys. Acta 861, 141-151.
Silhankova, L. (1959) Folia Microbiol. 4, 29-40.

Grant et al.
Stein, W. D. (1986) Transport and Diffusion Across Cell
Membrane, pp 141-145, Academic Press, New York.
Thron, C. D. (1964) J. Pharm. Exper. Ther. 145, 194-201.
Tosteson, M. T., Holmes, S.J., Razin, M., & Tosteson, D. C.
(1985) J . Membr. Biol. 87, 33-44.
Weinstein, J. W., Ralston, E., Leserman, L. D., Klausner, R. D.,
Dragsten, P., Henkart, P., & Blumenthal, R. (1984) in
Liposome Technology (Gregoriades, G.,Ed.) Vol. 111, pp 183204, CRC Press, Boca Raton, FL.
Williams, R. W., Starman, R., Taylor, K. M. P., Gable, K., Beeler,
T., Zasloff, M., & Covell, D. (1990) Biochemistry 29, 44904496.

Zasloff, M. (1987) Proc. Natl. Acad. Sci. U.S.A.84,5449-5453.
Zasloff, M., Martin, B., & Chen, H. (1988) Proc. Natl. Acad.
Sci. U.S.A. 85, 910-913.
Registry No. mgn2a, 1143 17-44- 1.

